BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2013
View Archived Issues
Novel TSPO PET radioligand described with low sensitivity to human genotypes
Read More
Janssen Research & Development joins MMRF's pre-competitive consortium for multiple myeloma
Read More
Results presented for clinical study of macimorelin in the treatment of cancer cachexia
Read More
InSite Vision regains rights to AzaSite Xtra
Read More
Luoxis Diagnostics reports results from first study of its proprietary diagnostic platform
Read More
Shield Therapeutics completes phase III enrollment for ST-10 in iron-deficient anemia
Read More
Tanzisertib proves to be well tolerated in vivo but clinical results lead to discontinuation
Read More
Phase II data reported for etrolizumab in ulcerative colitis
Read More
Results of a phase II study of brodalumab for asthma presented
Read More
A novel potent LPL activator improves plasma lipid levels in vivo
Read More
Researchers from Korea present phase II data for lobeglitazone
Read More
ACIP recommends Flublok influenza vaccine for adults with egg allergy
Read More
Anthera Pharmaceuticals begins phase II BRIGHT-SC study in IgA nephropathy
Read More
AtheroNova begins phase I study of AHRO-001
Read More
National Eye Institute supports stem cell research for patients with corneal blindness
Read More
FDA grants fast track designation to RBX-2660
Read More
Phase II results for C-Cure in heart failure reported, phase III study advances
Read More
Verona Pharma doses first patient in VRP-700 trial
Read More
DiaMedica provides update on DM-199 program for type 2 diabetes
Read More
Bristol-Myers Squibb patents new MGAT2 inhibitors
Read More
Novel opsin protein ligands designed by BIKAM Pharmaceuticals
Read More
Avanir's Nuedexta approved by the European Commission for pseudobulbar affect
Read More
Roche synthesizes novel BTK inhibitors
Read More
FDA approves pediatric indication for Mycamine
Read More
Basilea awarded BARDA contract for novel antibiotic
Read More
Researchers at Novartis divulge novel androgen receptor antagonists
Read More